drugset / Trial / NCT04650269

Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

NCT04650269

Phase 4 Completed 27 enrolled University of Miami Gilead Sciences · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if providing HIV medicine right away at the IDEA Syringe Services Program will help the participant start and remain in HIV care, including having no detectable HIV in the participant's blood.

Timeline

Start
2021-03-04
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Biktarvy Other / unclassified Oral